Triple negative breast cancers (TNBC) are a group of heterogeneous cancers characterized by their lack of estrogen receptor (ER), progesterone receptor (PR), and ErbB2/HER2/Neu [5]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.